Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:02190's Forward Dividend Yield % is ranked worse than 67.73% of 313
companies
in the Medical Devices & Instruments industry
Industry Median: 2.04
vs HKSE:02190: 1.26
Zylox-Tonbridge Medical Technology Co (HKSE:02190) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Zylox-Tonbridge Medical Technology Co Forward Dividend Yield % Related Terms
HKSE:02190 vs ABT, SYK, MDT: Forward Dividend Yield % Comparison
For the Medical Devices subindustry, Zylox-Tonbridge Medical Technology Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zylox-Tonbridge Medical Technology Co Forward Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zylox-Tonbridge Medical Technology Co's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Zylox-Tonbridge Medical Technology Co's Forward Dividend Yield % falls into.
Zylox-Tonbridge Medical Technology Co Forward Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Zylox-Tonbridge Medical Technology Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
HKD 0.251576
2026-05-27
2026-05-29
2026-06-18
Cash Dividend
annually
HKD:HKD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 1.26% mean?
Zylox-Tonbridge Medical Technology Co (HKSE:02190) has a Forward Dividend Yield % of 1.26% as of Aug. 17, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Zylox-Tonbridge Medical Technology Co and its competitors. According to the industry distribution chart, Zylox-Tonbridge Medical Technology Co ranks #212 out of 313 companies in the Medical Devices & Instruments industry, placing it in the top 67.7%.
Is Zylox-Tonbridge Medical Technology Co's Forward Dividend Yield % too high?
Zylox-Tonbridge Medical Technology Co's current Forward Dividend Yield % is 1.26%. The Medical Devices & Instruments industry median Forward Dividend Yield % is 2.04. Zylox-Tonbridge Medical Technology Co's value of 1.26% is 38.2% below this industry median. Based on the distribution chart, Zylox-Tonbridge Medical Technology Co ranks #212 out of 313 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Zylox-Tonbridge Medical Technology Co has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zylox-Tonbridge Medical Technology Co's Forward Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Zylox-Tonbridge Medical Technology Co ranks #212 out of 313 companies for Forward Dividend Yield %. This places Zylox-Tonbridge Medical Technology Co in the lower half of its industry. The industry median Forward Dividend Yield % is 2.04. Zylox-Tonbridge Medical Technology Co's value of 1.26% is 38.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.04, based on 313 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zylox-Tonbridge Medical Technology Co's current Forward Dividend Yield % of 1.26% is 38.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Zylox-Tonbridge Medical Technology Co and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zylox-Tonbridge Medical Technology Co's current Forward Dividend Yield % is 1.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zylox-Tonbridge Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Zylox-Tonbridge Medical Technology Co (HKSE:02190) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$35.80, compared to a current price of HK$19.95 — trading 44.3% below its estimated fair value. The current Forward Dividend Yield % is 1.26% and 38.2% below the Medical Devices & Instruments industry median of 2.04. Zylox-Tonbridge Medical Technology Co's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Zylox-Tonbridge Medical Technology Co (HKSE:02190), the current Forward Dividend Yield % is 1.26% as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zylox-Tonbridge Medical Technology Co (HKSE:02190) Overvalued in 2026?
Based on GuruFocus' analysis, Zylox-Tonbridge Medical Technology Co stock appears to be undervalued.
The current stock price of HK$19.95 is trading 44.3% below its estimated GF Value™ of HK$35.80.
GuruFocus considers Zylox-Tonbridge Medical Technology Co to be Significantly Undervalued.
Key valuation signals for HKSE:02190:
Forward Dividend Yield %: 1.26%
GF Value™: HK$35.80 vs. price of HK$19.95 (44.3% below fair value)
Industry Position: 38.2% below the Medical Devices & Instruments median (#212 of 313)
No single metric tells the full story. See the HKSE:02190 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zylox-Tonbridge Medical Technology Co Ltd is principally engaged in providing solutions to patients and physicians with a product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries. The company's products include Thrombite Clot Retriever Device (Thrombite CRD), Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB), and others. The company derives majority of its revenue from PRC.
81GF Score
Get the complete analysis for HKSE:02190
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02190 has been successfully added to your 
